Fundraising FoxPureTech Health — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Chimera Bioengineeringchimera.bioinApr 2022 · $8M
Chimera develops engineered cell therapies for cancer that produce therapeutic proteins only upon encountering tumor cells, using natural biological control mechanisms to improve safety and efficacy.
BiotechHealthtech
Co-investorsSand Hill AngelsShangBay Capital LLCWestern Technology Investment
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.